No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Pinning Down Royalty Pharma Plc's (NASDAQ:RPRX) P/S Is Difficult Right Now
Royalty Pharma Plc (NASDAQ:RPRX) Is Favoured by Institutional Owners Who Hold 72% of the Company
Jim Cramer Calls Royalty Pharma (RPRX) 'Disappointing' But Recommends Holding – 'I Want You To Stick With It'
TD Cowen Maintains Royalty Pharma(RPRX.US) With Buy Rating, Maintains Target Price $42
Royalty Pharma (RPRX) Gets a Buy From TD Cowen
Jim Cramer Likes Walmart, Recommends Buying This 'Very, Very Good' Financial Stock